GANZHOU HEMAY PHARMACEUTICAL CO., LTD.

赣州和美药业股份有限公司

Discovers and develops small-molecule drug candidates for autoimmune diseases and oncology, with a pipeline of seven candidates including one approved drug, targeting indications with unmet medical needs.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Supplier concentration
• Connected or related major customers / suppliers
• Reliance on platforms, partners or licences
• Pricing policy and price changes
• Outsourced production (OEM / contract manufacturing)
• Backlog and project economics
• Cash burn and runway
• Chapter 18A biotech
• Other